SCHEMBL3846794

SCHEMBL3846794

CS(=O)(=O)c1cc(F)cc(N2CCN(c3ncnc4ccc(Br)cc34)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 7/20 0.58
ALDH1A1 P00352 3/20 0.55
NPSR1 Q6W5P4 1/20 0.55
ACHE P22303 3/20 0.47
BACE1 P56817 3/20 0.47
PDGFRB P09619 4/20 0.43
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
KMT2A Q03164 1/20 0.41
HIF1A Q16665 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
ENPP1 P22413 1/20 0.41
MAPT P10636 1/20 0.39
AHR P35869 1/20 0.39
GBA1 P04062 1/20 0.39
RAB9A P51151 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3856238 0.83 HTT (0.60) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL3848366 0.82 HTT (0.57) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL3846080 0.81 HTT (0.58) HTTALDH1A1NPSR1ACHEBACE1
Hydrochloric Acid SCHEMBL3844654 0.80 AKT1 (0.47) HTTALDH1A1ACHEBACE1MAPK1
SCHEMBL30734225 0.80 HTT (0.67) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL3847513 0.76 CYP3A4 (0.42) HTTALDH1A1MAPK1MEN1LMNA
SCHEMBL4351530 0.75 HTT (0.71) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL3848130 0.75 HTT (0.71) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL4349956 0.74 HTT (1.00) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL30734188 0.74 HTT (0.69) HTTALDH1A1NPSR1ACHEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed